H.I.G. Capital Completes Sale Of Infusion Platform Soleo Health

Investment firm H.I.G. Capital sold its portfolio company Soleo Health, which provides infusion treatment services, to funds managed by Court Square Capital and WindRose Health Investors. Financial terms were not disclosed.

Soleo Health is a diversified, scaled, omnichannel infusion platform, delivering personalized health care to consumers with complex, rare, and ultra-rare medical conditions. It operates 26 pharmacies and more than 30 ambulatory infusion suites across the United States. Through its extensive pharmacy licensure and specialized nursing network, the company serves consumers across all 50 states.

During its ownership, H.I.G. supported Soleo’s growth by increasing . . .